Vertex Pharmaceuticals
VRTX
#175
Rank
โ‚ฌ100.30 B
Marketcap
391,21ย โ‚ฌ
Share price
-0.41%
Change (1 day)
-10.55%
Change (1 year)

Revenue for Vertex Pharmaceuticals (VRTX)

Revenue in 2025 (TTM): โ‚ฌ10.49 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚ฌ10.06 Billion. In 2024 the company made a revenue of โ‚ฌ10.58 Billion an increase over the revenue in the year 2023 that were of โ‚ฌ8.92 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Vertex Pharmaceuticals from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ10.49 B-0.89%
2024 โ‚ฌ10.58 B18.62%
2023 โ‚ฌ8.92 B7.23%
2022 โ‚ฌ8.32 B24.48%
2021 โ‚ฌ6.68 B32.56%
2020 โ‚ฌ5.04 B35.77%
2019 โ‚ฌ3.71 B39.49%
2018 โ‚ฌ2.66 B28.44%
2017 โ‚ฌ2.07 B28.17%
2016 โ‚ฌ1.61 B71.4%
2015 โ‚ฌ0.94 B97.84%
2014 โ‚ฌ0.47 B-45.62%
2013 โ‚ฌ0.87 B-23.98%
2012 โ‚ฌ1.15 B6.28%
2011 โ‚ฌ1.08 B907.75%
2010 โ‚ฌ0.10 B51.56%
2009 โ‚ฌ71.11 M-43.35%
2008 โ‚ฌ0.12 B-7.89%
2007 โ‚ฌ0.13 B-16.87%
2006 โ‚ฌ0.16 B20.73%
2005 โ‚ฌ0.13 B79.36%
2004 โ‚ฌ75.72 M43.12%
2003 โ‚ฌ52.9 M-65.67%
2002 โ‚ฌ0.15 B2.79%
2001 โ‚ฌ0.14 B79.36%
2000 โ‚ฌ83.57 M57.74%
1999 โ‚ฌ52.98 M55.24%
1998 โ‚ฌ34.12 M-7.53%
1997 โ‚ฌ36.91 M229.32%
1996 โ‚ฌ11.2 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Gilead Sciences
GILD
โ‚ฌ24.98 B 148.10%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ51.22 B 408.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ55.17 B 447.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ41.25 B 309.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ79.14 B 686.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
โ‚ฌ55.66 M-99.45%๐Ÿ‡บ๐Ÿ‡ธ USA